Differences In Blood Pressure Variability Research Articles

P218 MAY MEASUREMENT MONTH 2019: BLOOD PRESSURE VARIABILITY AND ITS RELATIONSHIP WITH HYPERTENSION AND COMORBIDITIES

Background and Objective: Within-visit blood pressure variability (BPV) is a predictor of cardiovascular events, independent of mean blood pressure (BP) levels. This study explored the associations of BPV with hypertension status and comorbidities in May Measurement Month (MMM) 2019 global survey participants. Methods: Adults (≥18 years) were surveyed via convenience sampling from 92 countries in May 2019. Each participant had up to three standardized seated BP readings. Participants with incomplete data on age or sex, or any missing BP readings were excluded. Hypertension was defined as having a BP ≥140 and/or 90 mmHg or being treated with BP-lowering medication. Participants were stratified into three groups: normotensive, untreated hypertensives, treated hypertensives, and normotensives. BPV was calculated as the variation independent of the mean (VIM) of the three BP readings. Associations between BPV and each of three conditions (previous stroke, previous myocardial infarction, or diabetes) were modelled using linear regression. Each model was adjusted for mean BP, age, sex, and an interaction term between age and sex. Results: Data from 1,128,889 participants were included. The mean age was 45.2 (SD 16.6) years and 51.4% were female. A third (33.6%) of participants were hypertensive, of whom 200,370 (53.2%) were treated. Of non-hypertensive and untreated hypertensive participants, those with a history of stroke, myocardial infarction, or diabetes had lower BPV relative to those without a history of these conditions (Figure). A stronger association was observed for diabetes within untreated hypertensive than non-hypertensive participants. However, amongst treated hypertensive participants, differences in BPV between those with comorbid conditions and those without were smaller than in the other two groups. Conclusions: Contrary to expectation, BPV was significantly lower in those with diabetes, or a history of stroke or myocardial infarction, amongst both untreated hypertensives and normotensives. However, among treated hypertensives, BPV was similar between those with or without each comorbidity, suggesting a modifying effect of BP-lowering medication.

The impact of novel coronavirus infection on blood pressure variability in patients undergoing painless gastrointestinal endoscopy

ObjectiveThis study aims to examine the impact of COVID-19 infection on blood pressure variability among patients undergoing painless gastrointestinal endoscopy. Materials and methodsWe conducted an analysis on a cohort of 53 patients who received painless gastroscopy at the First Affiliated Hospital of Zhengzhou University between November 2022 to January 2023. Non-invasive cuff pressure measurements were taken every minute upon the patient's arrival. Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Pressure (MAP), and Pulse Pressure (PP) were recorded both 5 min before and after induction. The variability in these parameters was calculated as the standard deviation (SD) over the mean, multiplied by 100%. Patients were grouped based on their history of COVID-19 infection. ResultsOur findings revealed significant differences in blood pressure variability between patients with a history of COVID-19 infection and those without. Prior to, substantial increases in variability were observed in DBP, MAP, and PP, while no significant change was in SBP. Following induction, COVID-19 positive patients exhibited heightened variability in all parameters. The most pronounced changes were seen in Pulse Pressure both before and after induction, suggesting a heightened cardiovascular response in patients with a history of COVID-19. These differences were statistically significant, indicating a clear impact of COVID-19 on cardiovascular stability during endoscopic procedures. ConclusionThe study underscores the influence of COVID-19 on increased blood pressure variability in patients undergoing painless gastrointestinal endoscopy. These findings highlight the need for vigilant cardiovascular monitoring in COVID-19 affected individuals during similar medical procedures.

SAT306 Comparison Of Sodium Nitroprusside And Urapidil In Laparoscopic Adrenalectomy For Pheochromocytoma

Abstract Disclosure: M.G. Rusalenko: None. E. Pispanen: None. M. Wisham: None. I. Savasteeva: None. S. Marchenko: None. D. Borovik: None. D.O. Rusalenko: None. The aim: of the study was to compare the efficacy of Sodium Nitroprusside and Urapidil in management of blood pressure in laparoscopic adrenalectomy for pheochromocytoma. Material and methods : This study includes of 58 cases of pheochromocytoma operated in the Republican Scientific and Practical Center for Radiation Medicine. The mean age of patients was 57.0 years (31 men and 27 women). For preliminary preparations, oral α1-blocker Doxazosin was used. In-operative blood pressure (BP) was recorded via intra-radial artery BP monitoring and via intra-venous BP monitoring from the external jugular vein. Fluid loading was done with colloids and crystalloids. Epidural anesthesia was given with a combination of Ropivacaine 10mg/ml-10ml and Spinal Morphine 1mg/ml-1-2ml was given between T4 - T5 for relaxation of the abdominal cavity. For anesthesia Sevoflurane was used with non-depolarizing short and medium-acting muscle relaxants (rocuronium, atracurium). In the study we included 12 patients who underwent surgery under BP control with Uradipil and 46 patients with Nitroprusside. Results: Long-term administered Doxazosin (more than 14 days) demonstrated lower BP values ​​in the starting phase of the operations (SBP 125.0[110.0; 130.0]; DBP [75.0(60.0; 80.0]) § (SBP 140.0[130.0; 150.0]; DBP [90.0(80.0; 90.0]); p<0.05. Statistically significant differences in BP variability from baseline to maximum values, as well as minimum values were obtained. In both groups (Nitroprusside and Urapidil), using the Wilcoxon criteria, we did not obtain significant differences in the increase in the initial blood pressure in maximum values. In contrast, in the Nitroprusside group, a statistically significant decrease in baseline blood pressure to the minimum values (SBP 90.0[75.0; 100.0]; DBP [50.0(50.0; 55.0]); p<0.004) was obtained, as in the Urapidil group: (SBP 130.0[ 110.0; 140.0]; DBP [80.0(60.0; 90.0]), to minimal values (SBP 95.0[90.0; 110.0]; DBP [60.0(50.0; 60.0]); p<0.008. Comparison of all blood pressure indicators when using Nitroprusside or Urapidil using the Mann-Whitney U test did not show statistically significant differences. However, there was a minor significance in minimum SBP values ​​(N 90.0[75.0; 100.0] § [U 95.0(90.0; 110.0]); z=-1.44; p=0.15) and DBP (N 50.0[50.0; 55.0] § [U 60.0(50.0; 60.0]); z=-1.81; p=0.07. Initial, maximum and final BP values ​​were equivalent in two groups. Conclusion: This data shows that to stabilize patient blood pressure in adrenalectomy for pheochromocytoma, preparation with α1-blockers is significant. The use of Sodium Nitroprusside and Urapidil is equally effective for managing BP during adrenalectomy, however, Urapidil shows to have advantages due to its lower side effects compared to Nitroprusside. Presentation: Saturday, June 17, 2023

Changes in Blood Pressure Variability in Children with Postural Tachycardia Syndrome.

(1) Objective: In this research, we explored the difference in blood pressure variability (BPV) between children with postural tachycardia syndrome (POTS) and healthy children. Furthermore, we tried to investigate the effect of BPV on POTS and its relationship with prognosis of POTS. (2) Methods: 47 children with POTS (11.2 ± 1.8 years, 23 males) were enrolled in the POTS group and 30 healthy children (10.9 ± 1.9 years, 15 males) were matched for the control group. All participants completed 24 h ambulatory blood pressure monitoring (24hABPM). Thirty-three children with POTS were followed up for 52.0 (30.5, 90.5) days and were divided into a response group and a non-response group after evaluation. (3) Results: The 24 h diastolic blood pressure standard deviation (24hDSD), daytime diastolic blood pressure standard deviation (DDSD), nighttime systolic blood pressure standard deviation (NSSD), daytime diastolic blood pressure variation coefficient (DDCV) and nighttime systolic blood pressure variation coefficient (NSCV) in the control group were lower than those in the POTS group (p < 0.05). Percentage of females, age and height were lower in the response group than in the non-response group in children with POTS (p < 0.05). Univariate analysis showed that 24hDSD, DDSD, NSSD, DDCV and NSCV were potential risk factors for POTS, and sex and height were potential risk factors for poor prognosis of POTS. After adjusting for covariates, the risk of POTS increased by 48%, 53% and 49% when DDSD, NSSD and NSCV increased by 1 mmHg, 1 mmHg and 1%, respectively. The risk of poor prognosis in females was 12.99 times higher than that in males. (4) Conclusions: The results suggest that children with POTS may have an abnormal circadian rhythm in blood pressure and increased BPV. DDSD, NSSD and NSCV are independent risk factors for POTS, and being female is an independent risk factor for poor prognosis of POTS.

Differences in Heart Rate Variability and Baroreflex Sensitivity between Male and Female Athletes.

Heart rate variability (HRV), systolic blood pressure variability (BPV), and spontaneous baroreflex sensitivity (BRS) are indirect and approximate measures of autonomic regulation of the cardiovascular system. Studies have shown differences in HRV and BRS between males and females; however, no study has observed differences in BPV, HRV, or BRS between male and female athletes. One hundred males (age 21.2 ± 2.1 y; BMI 27.4 ± 4.5 kg/m2) and sixty-five females (age: 19.7 ± 1.6 y; BMI 22.7 ± 2.2 kg/m2) were assessed during the pre-season baseline. We collected resting beat-to-beat blood pressure and R-R intervals using finger photoplethysmography and a 3-lead electrocardiogram, respectively. Participants underwent a controlled slow breathing protocol (six breaths/minute: 5 s inhale, 5 s exhale) for 5 min. Spectral and linear analysis was conducted on blood pressure and ECG data. Regression curves were fitted to the blood pressure and R-R signals, with the slopes providing the BRS parameters. Male athletes had significantly (p < 0.05) lower mean heart rate, RR interval SD2/SD1, HRV % low-frequency, and higher BP high-frequency power during controlled respiration. No differences were found in any BRS parameters. HRV and BPV responses to a slow breathing protocol differed between male and female athletes; however, BRS responses did not.

Twenty-four-hour ambulatory blood pressure variability and association with ischemic stroke subtypes in the subacute stage.

Blood pressure (BP) variability (BPV) increases the risk of cerebral disease in both hemorrhagic and ischemic strokes. However, whether BPV is associated with different types of ischemic stroke remains unclear. In this study, we explored the relationship between BPV and ischemic stroke subtypes. We enrolled consecutive patients aged 47-95 years with ischemic stroke in the subacute stage. We categorized them into four groups based on their artery atherosclerosis severity, brain magnetic resonance imaging markers, and disease history: large-artery atherosclerosis, branch atheromatous disease, small-vessel disease, and cardioembolic stroke. Twenty-four-hour ambulatory blood pressure monitoring was performed, and the mean systolic blood pressure/diastolic blood pressure, standard deviation, and coefficient of variation were calculated. A multiple logistic regression model and random forest were used to test the relationship between BP and BPV in the different types of ischemic stroke. A total of 286 patients, including 150 men (73.0 ± 12.3 years) and 136 women (77.8 ± 9.6 years) were included in the study. Of these, 86 (30.1%) patients had large-artery atherosclerosis, 76 (26.6%) had branch atheromatous disease, 82 (28.7%) had small-vessel disease, and 42 (14.7%) had cardioembolic stroke. There were statistically significant differences in BPV between subtypes of ischemic stroke in 24-h ambulatory blood pressure monitoring. The random forest model showed that BP and BPV were important features associated with ischemic stroke. Multinomial logistic regression analysis demonstrated that systolic blood pressure levels; systolic blood pressure variability at 24 h, daytime and nighttime; and nighttime diastolic blood pressure were independent risk factors for large-artery atherosclerosis after adjustment for confounders. When compared to branch atheromatous disease and small-vessel disease, nighttime diastolic blood pressure and standard deviation of diastolic blood pressure were significantly associated with patients in the cardioembolic stroke group. However, a similar statistical difference was not seen in patients with large-artery atherosclerosis. The results of this study indicate a discrepancy in blood pressure variability among different ischemic stroke subtypes during the subacute stage. Higher systolic blood pressure and systolic blood pressure variability during the 24 h, daytime, and nighttime, and nighttime diastolic blood pressure were independent predictors for large-artery atherosclerosis stroke. Increased nighttime diastolic BPV was an independent risk factor for cardioembolic stroke.

S-28-8: THE ASCOT LEGACY COHORT: THE LONG-TERM EFFECTS OF BLOOD PRESSURE AND BLOOD PRESSURE VARIABILITY ON CARDIOVASCULAR AND RENAL OUTCOMES

Introduction: We have previously shown that visit to visit systolic blood pressure variability (BPV) was the major predictor of cardiovascular outcomes in ASCOT, a trial in hypertensive participants randomised to amlodipine based or atenolol based treatment. Treatment differences in BPV accounted for the benefits of the amlodipine based regimen over the atenolol based regimen on cardiovascular (CV) events during the trial. We now report observations from the 20 yr follow up of UK participants to determine the long term impact of mean systolic blood pressure control during the trial and BPV on CV and renal outcomes. Methods: In the ASCOT Legacy Cohort, 7,092 hypertensive participants with hypertension, aged 40 to 79 years, with at least three other CV risk factors have been followed for up to 20 years. All available SBP visit records (n = 100,933) were included after excluding the first six months observations. The mean of SBP as a measure of BP control and the standard deviation (SD) of all SBPs as an estimate of visit to visit BPV were calculated for the five years of the trial. Participants were then followed for up to 15 years after the end of the trial using the UK National Health Service (NHS) electronic health records. CV and renal outcomes were measured using Cox proportional hazards model adjusted for confounding variables. Results: Although in trial mean SBP predicted long term CV and renal outcomes, SBP variability independent of mean SBP was a strong predictor of both CV and renal outcomes. (Table) Those originally assigned amlodipine based (vs. atenolol based) treatment had a significantly reduced long term risk of risk of stroke [0.82, 0.72 to 0.93, p = 0.003], total CV events and procedures [0.93, 0.88 to 0.98, p = 0.008], total coronary events [0.92, 0.86 to 0.99, p = 0.024] and atrial fibrillation [0.91, 95% CI, 0.83 to 0.99, p = 0.030]. There was no significant difference in the incidence of heart failure, non fatal myocardial infarction and fatal CHD or renal events. Conclusions: Amlodipine based treatment conferred long term advantages over atenolol based treatment on several CV outcomes. Both mean SBP and BPV are strong predictors of long term CV and renal outcomes, but BPV, independent of mean BP, confers a significant additional risk and should be considered for future preventive and therapeutic strategies.

Impairment on Cardiovascular Autonomic Modulation in Women with Migraine.

Autonomic dysfunction, such as reduced vagally mediated heart rate variability, has been suggested in headache patients but is still uncertain when considering primary headache disorders. This study aims to compare the heart rate and blood pressure variability and baroreflex sensitivity between women with migraine and controls. A migraine (n = 20) and a control group (n = 20) of age-matched women without headache were evaluated. Heart rate variability was analyzed through frequency-domain using spectral analysis presenting variance, low-frequency (LF; 0.04-0.15 Hz) and high-frequency (HF; 0.15-0.4 Hz) bands and by time domain (root mean square of successive R-R interval differences, RMSSD). Blood pressure variability was analyzed with spectral analysis and baroreflex sensitivity with the sequence method. Migraine group had lower heart rate variability characterized by a reduction in total variance, LF oscillations (sympathetic/vagal modulation) and HF oscillations (vagal modulation), and a reduction in SD and RMSSD compared to control group. No difference was found in the blood pressure variability analysis. Regarding baroreflex sensitivity, migraine group had decreased values of total gain, gain down and up compared to control group. Women with migraine exhibited autonomic modulation alterations, expressed by decreased values of heart rate variability and baroreflex sensitivity, but not by differences in blood pressure variability.

Effect of 3, 2-Drug Combinations of Antihypertensive Therapies on Blood Pressure Variability in Black African Patients: Secondary Analyses of the CREOLE Trial

The effect of 3 commonly recommended combinations of anti-hypertensive agents-amlodipine plus hydrochlorothiazide (calcium channel blocker [CCB]+thiazide), amlodipine plus perindopril (CCB+ACE [angiotensin-converting enzyme]-inhibitor), and perindopril plus hydrochlorothiazide (ACE-inhibitor+thiazide) on blood pressure variability (V) are unknown. We calculated the blood pressure variability (BPV) in 405 patients (130, 146, and 129 randomized to ACE-inhibitor+thiazide, CCB+thiazide, and CCB+ACE-inhibitor, respectively) who underwent ambulatory blood pressure monitoring after 6 months of treatment in the Comparisons of Three Combinations Therapies in Lowering Blood Pressure in Black Africans trial (CREOLE) of Black African patients. BPV was calculated using the SD of 30-minute interval values for 24-hour ambulatory BPs and for confirmation using the coefficient of variation. Linear mixed model regression was used to calculate mean differences in BPV between treatment arms. Within-clinic BPV was also calculated from the mean SD and coefficient of variation of 3 readings at clinic visits. Baseline distributions of age, sex, and blood pressure parameters were similar across treatment groups. Participants were predominately male (62.2%) with mean age 50.4 years. Those taking CCB+thiazide had significantly reduced ambulatory systolic and diastolic BPV compared with those taking ACE-inhibitor+thiazide. The CCB+thiazide and CCB+ACE-inhibitor groups showed similar BPV. Similar patterns of BPV were apparent among groups using within-clinic blood pressures and when assessed by coefficient of variation. Compared with CCB-containing combinations, ACE-inhibitor plus thiazide was associated with higher levels, generally significant, of ambulatory and within-clinic systolic and diastolic BPV. These results supplement the differential ambulatory blood pressure-lowering effects of these therapies in the CREOLE trial.

Does the Body Mass Index Category Influence Ambulatory Blood Pressure Parameters in Office Normotensive Obese Children?

The aim of our study was to investigate the influence of the degree of obesity on ambulatory blood pressure parameters in selected group of office normotensive obese children and adolescents. Our study involved 119 obese patients (55 males, 46.2%) aged 7-18years divided into 3 groups based on their body mass index Z-score, who underwent ambulatory blood pressure monitoring. Our results show that obese patients, even when office normotensive, have alterations in blood pressure values obtained by ambulatory blood pressure monitoring. We found a positive correlation between systolic and diastolic blood pressure and body mass index in our patients (p [Formula: see text]0.001). Daytime blood pressure load correlated with rising body mass index and was higher in groups II and III compared to group I (p < 0.001). Body mass index category did not influence the dipping pattern in our subjects although most of our subjects (66.4%) showed non-dipping pattern for systolic blood pressure. The difference in blood pressure variability was confirmed only for daytime systolic and diastolic values between groups I and II (p = 0.019 and p = 0.002, respectively). In conclusion, our study showed that in office normotensive obese children and adolescents, systolic and diastolic blood pressure values obtained by ambulatory blood pressure monitoring are higher in subjects with higher body mass index. Patients with increased body mass index also have higher percentage of blood pressure readings above 95th percentile and increased daytime blood pressure variability. Obese patients show non-dipping pattern, independently of the rising body mass index category.

Ambulatory Blood Pressure Variability after Adenotonsillectomy in Childhood Sleep Apnea.

To investigate the influence of adenotonsillectomy (T&A) on ambulatory blood pressure (BP) variability in children with obstructive sleep apnea (OSA). Prospective, interventional study. Children with OSA symptoms were recruited from a tertiary center. After OSA diagnosis was confirmed (ie, apnea-hypopnea index [AHI] > 1), these children underwent T&A for treatment. We performed polysomnography and 24-hour recordings of ambulatory BP before and 3 to 6 months postoperatively. Ambulatory BP variability was presented as the standard deviation of mean blood pressure in the 24-hour monitoring of ambulatory BP. Differences in BP variability among different subgroups were tested using a multivariable linear mixed model. A total of 190 children were enrolled (mean age: 7.8 ± 3.3 years; 73% were boys; 34% were obese). The AHI significantly decreased from 12.3 ± 17.0 to 2.7 ± 5.5 events/hr after T&A. Overall, daytime, and nighttime ambulatory BP did not significantly change postoperatively, and overall, daytime, and nighttime ambulatory BP variability did not differ significantly preoperatively and postoperatively. In the subgroup analysis, children aged <6 years demonstrated a significantly greater decrease in ambulatory BP variability postoperatively than those aged >6 years (nighttime diastolic BP variability: 9.9 to 7.7 vs. 8.9 to 9.4). Children with hypertension also showed a significantly greater decrease in ambulatory BP variability than those without hypertension. We concluded that overall ambulatory BP variability does not significantly change after T&A in children with OSA. Moreover, young-aged and hypertensive children demonstrate a significant decrease in BP variability after T&A. 4 Laryngoscope, 132:2491-2497, 2022.

Supine blood pressure normalised by daytime series values is independently associated with ischaemic wake-up stroke

Purpose Wake-up stroke constitutes up to 1/4 of all ischaemic strokes; however, its pathomechanisms remain largely unknown. Although low nocturnal blood flow may be the underlying cause, little is known about blood pressure (BP) characteristic of wake-up stroke patients. The aim of our study was to look for differences in BP variables between wake-up stroke and known-onset stroke patients and to seek BP indices which could distinguish wake-up stroke patients from other stroke patients. Materials and Methods In the study, we included ischaemic stroke patients in whom office BP measurement and Ambulatory BP monitoring (ABPM) were recorded at day 7, after acute hypertensive response. The daytime period was defined as the interval from 6 a.m. to 10 p.m. From ABPM, we obtained parameters of BP variability. Additionally, we calculated the BP percentage differences defined as (supine office BP–average daytime BP)/average daytime BP for systolic, diastolic, and mean blood pressure. We calculated analogous indices for night-time. The univariate and multivariate relationships between BP variables and wake-up stroke were analysed. Results Among the recruited 120 patients (aged 61.6 ± 12.3; 88 [73%] males; the baseline National Institutes of Health stroke scale score 4 [3–8]), 36 (30%) had wake-up stroke. In a univariate analysis, the systolic and mean daytime and night-time BP differences were significantly lower in patients with wake-up stroke [(−1.92 (−11.55 to 3.95) vs 4.12 (−2.48 to 11.31), p = 0.006 and −6.20 (−12.32 to 7.42) vs 2.00 (−6.86 to 11.65), p = 0.029 for daytime, respectively; 0.00 (−9.79 to 11.82) vs 9.84 (0.00 to 18.25), p = 0.003 and 0.51 (−8.49 to 12.08) vs 7.82 (−2.47 to 20.39), p = 0.026, for night-time, respectively]. After adjustment for possible confounders, the systolic BP difference remained significantly associated with wake-up stroke (odds ratio = 0.96, 95% confidence interval = 0.92–1.00, p = 0.039). Conclusion The subacute office-ambulatory BP difference including the dynamic (systolic BP), but not static BP component was independently associated with wake-up stroke.

Abstract TMP60: Association Of Blood Pressure Variability With Death And Discharge Destination Among Stroke And Non-stroke Critical Illness Patients

Introduction: High blood pressure variability (BPV) is associated with worse prognoses among critically ill stroke and non-stroke patients. It is unclear if higher BPV’s association with worse outcomes is a unique sequela of stroke or a modifiable risk factor among all critically-ill patients. Methods: Using data from 7,939 ICU patients hospitalized between 2001 and 2012 in the Medical Information Mart for Intensive Care III (MIMIC-III) database, we examined (1) differences in BPV between stroke and non-stroke patients, (2) BPV’s associations with in-hospital death and favorable discharge destination in stroke and non-stroke patients after adjusting for confounders, and (3) how minimum systolic blood pressure (SBP) - a correlate of illness severity and cerebral perfusion - affected these associations. Results: BPV was higher in stroke patients compared to non-stroke patients. In regression analyses, higher BPV was significantly associated with higher odds of in-hospital death and unfavorable discharge amongst stroke and non-stroke patients. After adjusting for minimum tertile of SBP to account for illness severity and cerebral perfusion, higher BPV was significantly associated with higher odds of in-hospital death and lower odds of favorable discharge destination only in patients with ischemic stroke (OR in-hospital death 2.1, 95% CI: 1.0-4.1; OR favorable discharge 0.6, 95% CI: 0.4-0.9) or intracerebral hemorrhage (OR in-hospital death 3.3, 95% CI: 1.8-6.1; OR unfavorable discharge 0.4, 95% CI: 0.3-0.7). Conclusion: Among critically ill stroke patients, BPV seems to represent both generalized critical illness as well as a specific feature of stroke. BPV in critically ill stroke patients may be in part a function of injury to the central autonomic network or modulation of sympathetic outflow.

Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?

PurposeTo assess the safety and efficacy of continuous infusion (CIV)-labetalol compared to -nicardipine in controlling blood pressure (BP) in the acute stroke setting. MaterialsPatients were eligible if they had a diagnosis of an acute stroke and were administered either CIV-labetalol or CIV-nicardipine. Study outcomes were assessed within the first 24 h of the antihypertensive infusion. ResultsA total of 3,093 patients were included with 3,008 patients in the CIV-nicardipine group and 85 in the CIV-labetalol group. No significant difference was observed in percent time at goal BP between the nicardipine (82%) and labetalol (85%) groups (p = 0.351). There was also no difference in BP variability between nicardipine (37%) and labetalol (39%) groups (p = 0.433). Labetalol was found to have a shorter time to goal BP as compared to nicardipine (24 min vs. 40 min; p = 0.021). While CIV-nicardipine did have a higher incidence of tachycardia compared to labetalol (17% vs. 4%; p <0.001), the incidence of hypotension (13% vs. 15%; p = 0.620) and bradycardia (24% vs. 22%; p = 0.797) were similar. ConclusionsThese results indicate that CIV-labetalol and CIV-nicardipine are comparable in safety and efficacy in controlling BP for patients with acute stroke.

Sex Differences in Blood Pressure Variability in response to Sodium and Potassium Diets

It is well established that Americans consume more salt than recommended by the Dietary Guidelines for Americans. High sodium diets have been shown to increase blood pressure (BP) while dietary potassium is known for its BP lowering properties. Elevated BP variability (BPV), as indicated by spontaneous fluctuations in BP, is associated with cardiovascular morbidity and mortality. Although no recommendations exist for targeting elevated BPV, understanding how different dietary components affect BPV could be important to reduce CVD. Limited literature from rodent and human studies suggests a relation between a high sodium diet and an increased BPV. Additionally, mechanisms regulating BP between men and women differ which may lead to the hypothesis that BPV differs as well. Thus, the interactive effects of dietary sodium and potassium on BPV in humans are unknown as well as whether potential sex differences exist. The purpose of this study was to compare BP and BPV responses to varying dietary levels of sodium and potassium in salt-resistant, healthy, normotensive young adults. Twenty women (27±1 yrs. old; SBP: 112±3 mmHg; DBP: 71±1 mmHg; BMI: 24.1±0.7 kg/m2) and 17 men (26±1 yrs. old; SBP: 117±3 mmHg; DBP: 75±2 mmHg; BMI: 24.4±0.7 kg/m2) completed 7 days each of the following diets: moderate potassium/low sodium diet (65 mmol potassium/50 mmol sodium; MK/LS), a moderate potassium/high sodium diet (65 mmol potassium/300 mmol sodium; MK/HS) and a high potassium/high sodium (120 mmol potassium/300 mmol sodium; HK/HS) in random order. BP and BPV were calculated from 24 h ambulatory BP monitoring on day 6 of each diet. Average Real Variability (ARV) was used as an index of BPV. A mixed-model ANOVA was performed with a Tukey post hoc test with diet as a within subject factor and sex as a between subject factor to determine whether differences existed between men and women on each diet. For 24 h SBP, the main effect of sex was significant (p=0.01) and the sex*diet interaction was significant (p=0.03) such that men had a higher 24 h SBP than women on the HK/HS diet (117±2 mmHg vs 112±1 mmHg, p=0.02). On the MK/LS and MK/HS diets, 24 h SBP was not different between men and women (p>0.05). For 24 h DBP, the main effect of diet was significant (p=0.009) such that 24 h DBP was higher on the MK/LS diet vs HK/HS diet (69±1 mmHg vs 67±1 mmHg, p=0.01) and higher on MK/LS diet compared to MK/HS diet regardless of sex (69±1 mmHg vs 68±1 mm Hg, p=0.02). For 24 h SBP ARV, the main effects of diet and sex and the interaction of sex*diet were not significant (all p>0.05). For 24 h DBP ARV, the main effect of sex was significant (p=0.006) such that men had higher variability regardless of diet (9±0.2 mmHg vs 7±0.2 mm Hg). Our results suggest that in the context of a high sodium diet, potassium may help lower BP in women but not in men. In addition, men tended to have a higher BPV compared to women regardless of the diet. Future studies are warranted to further study the differential response of men and women to the effectiveness of dietary interventions for reducing CVD risk.

Association of central blood pressure profile, ambulatory blood pressure parameters with 2D echocardiographic diastolic dysfunction and carotid intima-media thickness in patients with coronary artery disease

Introduction: Blood Pressure (BP) and its diurnal variability are linked to endothelial dysfunction and arterial stiffness, promoting atherosclerosis which can be observed as intimal thickening in carotid arteries and atherosclerotic lesions in coronary angiograms. Objectives: To evaluate the association of Diastolic Dysfunction (DD) in patients with Coronary Artery Disease (CAD) with central and Ambulatory Blood Pressure Monitoring (ABPM) indices and to assess Carotid Intima Media Thickness (CIMT) in different CAD score groups and then to compare the results with individuals having normal coronaries. Methodology: A descriptive cross-sectional study was conducted at Cardiology Unit Kandy in 2017/18. Patients undergoing elective coronary angiography were categorized in to low, intermediate and high SYNTAX score group. Invasive BP was recorded and Pulsatility Index (PI) was derived. Carotid ultrasound was used to assess CIMT and diastolic function was assessed by 2D echocardiogram. Patients had their 24-hour ABPM recorded. Results were compared with individuals having normal coronary arteries on angiogram. Results: There were a total of 60 subjects out of which 40 (Mean age=59.77±8.73years) had angiographically proven CAD and 20 subjects had no CAD on angiogram. Amongst the CAD group the calculated PI was 0.82±0.36. The ratio of early diastolic mitral inflow velocity to annular velocity (E/e’) which denotes diastolic dysfunction, had strong positive correlation with PI (r=0.942, p=0.002). The mean CIMT for right and left carotid arteries were 0.62±0.11mm and 0.65±0.13mm respectively. A higher but statistically insignificant (p=0.087) CIMT value was noted among patients with SYNTAX score ≥ 23 (7.55±3.01) than in SYNTAX score ≤ 22 (6.87±1.93). Low SYNTAX score group had 45%, (n=18) abnormal dipping pattern in ABPM whereas only 12.5%, (n=05) in the intermediate to high score group showed this pattern, which was statistically highly significant (X2=30.7, p=0.004). Between the CAD group and subjects having normal coronary arteries, the following parameters did not show statistically significant difference. Invasively derived PI (0.76±0.17 and 0.78±0.15, p=0.318), ABPM-derived atherogenic index (r=0.005, p=0.658 and r=0.003, p=0.554), CIMT value (0.63±0.10 mm and 0.52±0.19 mm, p=0.196) and the mitral annular E/e’ velocity (9.56±5.40 and 10.81±3.22, p=0.372). Conclusion: Diastolic dysfunction which is reflected by E/e’ positively correlated with invasively derived PI which indicate incipient arterial stiffness. Therefore E/e’ could be used as a non-invasive tool to assess arterial stiffness indirectly. In ABPM, statistically significant abnormal dipping pattern was observed in low SYNTAX group compared to high group which demonstrates the difference in BP variability and haemodynamic diversity amongst CAD patients with different atherosclerotic disease burden. These findings reflect the usefulness of non-invasive parameters such as E/e’ and CIMT to predict the extent of coronary artery disease and the need for further detailed studies in this field using large patient population in order to find out the best non-invasive parameter which independently predict the CAD burden.

Sleeve gastrectomy prevents hypertension associated with unique shifts in the gut microbiome.

Bariatric surgery results in resolution of hypertension in over 50% of patients. While weight loss is a critical component to hypertension resolution after bariatric surgery, there may also be weight loss-independent mechanisms. We hypothesized that sleeve gastrectomy (SG) initiates changes in the gut microbiome which reduce postoperative blood pressure. Male, obese Zucker rats underwent SG, pair-fed sham, or ad-lib-fed sham surgery. Blood pressure measurements were performed 1 week pre-operatively, and at 2 and 6weeks post-operatively. The stool microbiome composition was determined by 16S rDNA gene at 6weeks post-operatively. Regression Random Forest modeling was performed to determine an association of the microbial composition with blood pressure. SG and pair-fed rats weighed significantly less than ad-lib-fed sham rats throughout the post-surgical period. At 6weeks after surgery, SG rats had a significantly lower systolic blood pressure (149.2 ± 1.99mmHg) than pair-fed (164.7 ± 7.87, p < 0.001) or ad-lib-fed sham rats (167.1 ± 2.41mmHg, p < 0.001). There was a significant difference in multiple measures of beta diversity between SG rats and pair-fed and ad-lib-fed sham rats. 45.11% of the difference in blood pressure variability between samples was explained with the regression Random Forest model. SG in a rat model prevented hypertension progression independent of weight loss with changes in beta diversity and gut bacterial composition associated with the blood pressure outcome. These findings further support the metabolic efficacy of SG in treating hyperglycemia, cardiac dysfunction, and now hypertension, independent of obesity class.

The Get-Up! study: adiposity and blood pressure in Australian toddlers.

Background:Because the elevated blood pressure (BP) in childhood is strongly associated with overweight and is a risk factor for later cardiovascular disease, a need to comprehend the early development of BP and its association with overweight is needed. We assessed differences of BP by weight status in Australian toddlers.Methods:From the Get-Up! Study in Australia, this sample included 265 toddlers (136 boys), aged 19.6 ± 4.2 months. BP was measured with a digital vital signs monitor. Participants were categorized as nonoverweight and overweight according to the World Health Organization definition for body mass index (BMI). Physical activity was captured with activPAL accelerometers, during childcare hours. To test differences in BP between nonoverweight and overweight children, we performed an analysis of covariance adjusting for sex, age, physical activity, and socioeconomic status.Results:Children with overweight showed higher z systolic BP values (P = .042 for BMI and P = .023 for waist circumference) when compared to nonoverweight children. However, no differences were found for z diastolic BP levels, between overweight and nonoverweight children. After adjustments for potential confounders (socioeconomic status, physical activity, sex, and age), there were no significant differences in BP variables between BMI and waist circumference groups.Conclusions:No associations between adiposity and BP levels were found in this sample. The unadjusted results, however, showed that children with higher levels of adiposity (BMI and waist circumference) exhibited higher levels of BP. Additional research is needed to determine which environmental and genetic factors might contribute to pediatric hypertension, particularly among toddlers.

Comparison of day-to-day blood pressure variability in hypertensive patients with type 2 diabetes mellitus to those without diabetes: Asia BP@Home Study.

Blood pressure variability (BPV) has been shown to be independently associated with cardiovascular (CV) mortality and morbidity. Patients with type 2 diabetes mellitus (T2DM) have also been shown to have increased BPV. We aimed to compare BPV in hypertensive patients with diabetes with those without diabetes. A total of 1443 hypertensive patients measured their blood pressure (BP) twice in the morning and twice before bed at home for a week. Demographic data, history of T2DM, and anti-hypertensive use were captured. Clinic BP was measured twice in the clinic. Control of BP was defined as clinic systolic BP (SBP) <140mmHg and home SBP<135mmHg. BPV was based on home SBP measurements. A total of 362(25.1%) hypertensives had diabetes and 47.4% were male. Mean age was 62.3±12.1years. There was no difference in the mean clinic SBP in both groups (139.9mmHg vs 138.4mmHg P=.188). However, the mean morning home SBP was significantly higher and control rate lower in hypertensives with diabetes than those without (132.3±15mmHg vs 129.7±14.4mmHg P=.005, 39.4% vs 47.6% P=.007), respectively. Masked uncontrolled morning hypertension was higher in those with diabetes versus those without (12.8% vs 8.4%, respectively). There was no statistically significant difference in BPV between those with and without diabetes. In summary, clinic SBP was similar in hypertensives with or without diabetes. However, control of BP based on both clinic and home SBP thresholds was poorer in hypertensives with diabetes compared to those without. Masked uncontrolled morning hypertension was higher in those with diabetes than those without. There was no difference in BPV between the two groups.

Abstract 029: Antihypertensive Treatment and Short-Term Blood Pressure Variability

Blood pressure variability (BPV) is recognized as an important prognostic contributor in hypertension. We asseseds differences in short-term BPV in treated patients depending on the number of drugs, drug-classes and combinations, and individual compounds. From the Spanish ABPM Registry, we selected 38188 treated patiens. BPV estimates were obtained from ABPM records, and included weighted, daytime and nighttime SD and average real variability (ARV). Comparisons (general linear models adjusted for age, gender, diabetes, dyslipidemia and CV disease) were carried out depending on the number of drugs (1, 2, 3, and more). In patients treated with monotherapy (13765), BPV estimates were compared depending on the drug classes, as well as on individual compounds inside each class. Additional comparisons were performed depending on the type of combination in patients treated with 2 (12716) and 3 drugs (7888). Systolic BPV increased from monotherapy to treatment with 4 or more drugs (p&lt;0.001 for weighted, daytime, and nighttime SD, and ARV). Among those treated with monotherapy, BPV was increased in those treated with beta blockers, ACEi and ARB, when compared to diuretics or CCB. No differences were observed among diuretics (chlorthalidone, hydrochlorothiazide, indapamide, or loop diuretics). Among betablockers, BPV was increased in those treated with carvedilol, compared to bisoprolol and nevibolol. Among CCB, BPV was lower in treated with amlodipine, with respect to other dihydropyridines. No differences were observed among most frequent used ACEi or ARB. In patients treated with 2-drug combinations, BPV was lower in those treated with diuretic/CCB combinations, compared with other types. Moreover, in those treated with 3-drug combinations, those which included a CCB resulted in a lower BPV in comparison to those which did not include a CCB. Results regarding diastolic BPV were consistent with those observed with systolic BPV. We conclude that antihypertensive treatment is associated with differences in BPV. CCB, specifically amlodipine, used in monotherapy or in combination with other drugs, especially diuretics, is associated with lower short-term BPV. These results may help to explain some benefits of amlodipine observed in clinical trials.